2025 PharmSci 360 Conference to Highlight AI in Drug Development and Gene Therapy Advancements

The 2025 PharmSci 360 conference will focus on advancements in artificial intelligence (AI) for drug development, progress in gene therapy, and key insights from pharmaceutical research. Mei He, the programming chair for the event, confirmed these topics as central themes for this year’s gathering.

The conference aims to showcase cutting-edge developments in AI technology that are shaping the future of drug discovery and development processes. It will also feature discussions on advancements in gene therapy techniques and their applications within the pharmaceutical industry. Additionally, attendees can expect presentations and panels highlighting recent breakthroughs and trends in pharma research. The event seeks to bring together experts from various fields to share knowledge and explore innovative solutions for challenges facing the industry.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: November 7, 2025

Related posts:

Biosimilar Developers Face Regulatory Hurdles Amidst Projected $150 Billion Market by 2025 Two Unresolvable Red Flags Identified in Pharmaceutical Prescribing and Dispensing Practices Metsera Reports Promising Early Results for Obesity Drug Targeting Amylin Hormone Google Home App Updates Introduce AI Features and Subscription-Based Premium Tools

Author

GOAI